Posters presented at the 2026 European Society for Medical Oncology (ESMO) Congress in Madrid examined how genomic testing ...
Sunvozertinib is FDA approved for patients with NSCLC with EGFR exon 20 insertion mutations that progressed on or after platinum-based chemotherapy. The oral EGFR inhibitor sunvozertinib (Zegfrovy) is ...
Everyday Health on MSN
Surprise mutation driving early start to flu season
Experts say this year’s flu shot still offers substantial protection against hospitalization.
Prime editing is an advanced form of CRISPR gene editing that allows scientists to make targeted changes to DNA, including ...
The start-up is the brainchild of a founder of Anduril, the military tech firm, and Colossal Biosciences, a biotech company ...
New findings suggest that a blood test can detect circulating tumor DNA (ctDNA), potentially identifying signs of lung cancer ...
Oric Pharmaceuticals presented new first-line NSCLC clinical data for enozertinib with EGFR atypical mutations and plans a ...
By Larry Luxner From his fourth-floor lab at the Technion-Israel Institute of Technology, Professor Ron Kimmel can see Haifa ...
New Study on ESR1 Mutations in Metastatic Breast Cancer / Breast Cancer, cancer, Clinical Cancer Research, David Spetzler, ...
Scientists in Sweden built and evaluated 15,000 genetically modified versions of bacterial Rubisco, the enzyme that captures carbon dioxide for growth. The post Swedish research team screens 15,000 ...
Scientists in Sweden built and evaluated 15,000 genetically modified versions of bacterial Rubisco, the enzyme that captures ...
A first-of-its-kind cancer vaccine is significantly reducing the chances that melanoma patients’ tumors come back.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results